Polycomplex gel for treating diseases of intestinal/digestive tract
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology for digestive tract diseases and complexes, applied in the field of polycomplex gels for the treatment of intestinal/digestive tract diseases, to achieve the effect of preventing disease recurrence, good penetration ability, and stable curative effect
Inactive Publication Date: 2017-08-18
格力佐维特有限责任公司
View PDF0 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
This results in the preparation being used only under medical supervision and requiring routine analysis of blood and urine
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0073] For the treatment of nonspecific ulcerative colitis, a polyplex gel with the following composition can be applied:
[0074] Metronidazole: 1.0g;
[0075] Thymogen: 0.01g;
[0076] Carbomer: 1.0g;
[0077] Propylene glycol: 10.0g;
[0078] EDTA disodium salt: 0.05g;
[0079] Propyl p-hydroxybenzoate: 0.02g;
[0080] Methylparaben: 0.04g;
[0081] Sodium hydroxide: sufficient to provide the necessary pH;
[0082] Distilled water: balance.
Embodiment 2
[0084] For the treatment of Crohn's disease, a polyplex gel with the following composition can be applied:
[0085] Metronidazole: 0.8g;
[0086] Thymogen: 0.002g;
[0087] Carbomer: 1.0g;
[0088] Propylene glycol: 10g;
[0089] EDTA disodium salt: 0.04g;
[0090] Propyl p-hydroxybenzoate: 0.025g;
[0091] Methylparaben: 0.04g;
[0092] Sodium hydroxide: sufficient to provide the necessary pH;
[0093] Distilled water: balance.
Embodiment 3
[0095] For the treatment of fistulas, polyplex gels with the following composition can be used:
[0096] Metronidazole: 1.2g;
[0097] Thymogen: 0.015g;
[0098] Carbomer: 1.0g;
[0099] Propylene glycol: 10g;
[0100] EDTA disodium salt: 0.05g;
[0101] Propyl p-hydroxybenzoate: 0.02g;
[0102] Methylparaben: 0.04g;
[0103] Sodium hydroxide: sufficient to provide the necessary pH;
[0104] Distilled water: balance.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to the chemical and pharmaceutical industry and consists of a rectal gel substance for treating diseases of the intestinal / digestive tract, including nonspecific ulcerative colitis, Crohn's disease, fistulae, etc., and also complications during the course of treatment of said diseases. The invention provides an antimicrobial and antiprotozoal effect and has good penetration capabilities. The technical result achieved by carrying out the claimed invention consists in increasing the effectiveness of treating non-infectious inflammatory diseases of the intestinal / digestive tract, and in shortening the duration of treatment. Said technical result is achieved by means of a polycomplex gel for treating diseases of the intestinal / digestive tract, said gel containing metronidazole and thymogen as active substances, and containing the following auxiliary substances, in the following composition and ratio of components, in grams, with a total mass of gel of 150 grams: metronidazole: 0.1-2g; thymogen: 0.001-0.05g; carbopol: 0.2-1.0g; propylene glycol: 8.0-11.0g; EDTA disodium salt: 0.001-0.08g; propyl parahydroxybenzoate: 0.015-0.04g; methyl parahydroxybenzoate: 0.035-0.08g; sodium hydroxide: an amount sufficient for producing the necessary pH; distilled water: the remainder.
Description
[0001] field of invention [0002] The present invention relates to the chemical and pharmaceutical industries and consists of a rectal gel substance for the treatment of intestinal / digestive tract diseases including non-specific ulcerative colitis, Crohn's disease, fistulas etc. and complications arising during the course of the disease. [0003] The present invention provides antimicrobial and antiprotozoal action and good penetration capabilities. [0004] Background of the invention [0005] Non-infectious intestinal / digestive tract inflammatory diseases such as ulcerative colitis and Crohn's disease have become one of the most serious problems in modern gastroenterology. The incidence of ulcerative colitis and Crohn's disease is increasing every year and occurs mainly in the adult population, making them socially important diseases. [0006] The similarity of these intestinal / digestive tract insults is due to the fact that they are the basis of chronic destruction of the...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more